Today: September 30, 2024
Today: September 30, 2024

Latest From Reuters

Business|Health

Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports

Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the

Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Environment|Health

Climate change threatens low-lying Caribbean hospitals, UN says

Tens of millions of people living in coastal areas around the Caribbean and Latin America face imminent risks to healthcare and key infrastructure as climate change brings more severe

Climate change threatens low-lying Caribbean hospitals, UN says
Business|Economy|Health

Brazil plans to raise minimum cigarette price, source says

Brazil's finance ministry plans to raise the minimum cigarette price to offset losses from tax benefits granted to companies in some sectors and small municipalities, a government

Brazil plans to raise minimum cigarette price, source says
Health

Fire kills six newborns at baby hospital in India's capital

Six newborns have died in a fire at a baby care hospital in India's capital New Delhi, local authorities said on Sunday.

Fire kills six newborns at baby hospital in India's capital
Health

Tobacco industry aims to hook new generation on vapes, WHO says

Tobacco companies still actively target young people via social media, sports and music festivals and new, flavoured products, the World Health Organization (WHO) said on Thursday,

Tobacco industry aims to hook new generation on vapes, WHO says
Business|Health

CVS seeks private equity funding for Oak Street Health, Bloomberg News reports

CVS Health Corp has been seeking a private equity partner to fund growth at Oak Street Health, a primary care provider it bought a year ago, Bloomberg News reported on Thursday.

CVS seeks private equity funding for Oak Street Health, Bloomberg News reports
Business|Health

Medtronic's weaker-than-expected outlook clouds quarterly results beat

Medtronic beat estimates for fourth-quarter revenue and profit on Thursday, helped by robust sales of its medical devices, but shares declined more than

Medtronic's weaker-than-expected outlook clouds quarterly results beat
Environment|Health|Lifestyle

From wedding photographer to water queue: Gaza mother mourns lost dream life

Falasteen Abdulati mourns her vanished good life as a wedding photographer as she wearily queues day after day for scarce drinking water in a

From wedding photographer to water queue: Gaza mother mourns lost dream life
Health

UK's anti-smoking laws could be lost in pre-election parliamentary rush

Britain's proposed law to ban smoking for younger generations could be shelved after Prime Minister Rishi Sunak called a surprise election, putting one of his flagship policies in

UK's anti-smoking laws could be lost in pre-election parliamentary rush
Business|Economy|Health

Carlyle Group exits Brazil's Rede D'Or -reports

Private equity firm Carlyle Group has sold all of its minority stake in Brazilian hospital chain Rede D'Or, local outlets Brazil Journal and Valor Economico reported on Wednesday.

Carlyle Group exits Brazil's Rede D'Or -reports
Business|Economy|Health

Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027

U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it

Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Business|Health

Biogen in up to $1.8 billion deal as rare diseases take center stage

Biogen said on Wednesday it had agreed to buy privately held Human Immunology Biosciences for up to $1.8 billion, bulking up on rare disease medicines as its older multiple sclerosis drugs

Biogen in up to $1.8 billion deal as rare diseases take center stage
Business|Health

Eli Lilly's diabetes drug tirzepatide gets approval in China

Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, setting up intensifying competition with its Danish rival Novo Nordisk in the

Eli Lilly's diabetes drug tirzepatide gets approval in China
Business|Health

Shah Capital ends campaign against Novavax board after Sanofi deal

Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors on Novavax's board, after the COVID-19 vaccine maker struck a licensing deal

Shah Capital ends campaign against Novavax board after Sanofi deal
Business|Health

J&J-backed startup Rapport files for US IPO

Biopharmaceutical company Rapport Therapeutics, backed by the venture capital arm of Johnson & Johnson, filed for an initial public offering in the United States on Friday.

J&J-backed startup Rapport files for US IPO
Business|Health

GSK raises $1.5 billion from sale of remaining Haleon stake

British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

GSK raises $1.5 billion from sale of remaining Haleon stake
Business|Economy|Health

Cannabis stocks rally after DOJ proposal to reclassify marijuana

Cannabis stocks including Tilray, Curaleaf, and the AdvisorShares Pure US Cannabis ETF rallied on Thursday after the U.S.

Cannabis stocks rally after DOJ proposal to reclassify marijuana
Business|Health

Johnson & Johnson to acquire Proteologix for $850 million

Johnson & Johnson said on Thursday it would acquire Proteologix for $850 million in cash, as it looks to gain access to the privately held company's experimental atopic dermatitis

Johnson & Johnson to acquire Proteologix for $850 million
Business|Health

Novo Nordisk is optimistic that Kalundborg fire won't delay expansion

Novo Nordisk said on Thursday it was "optimistic" that a fire at a construction site in Kalundborg, Denmark, a key manufacturing hub, would not delay its plans to boost

Novo Nordisk is optimistic that Kalundborg fire won't delay expansion
Business|Health

Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports

Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported on

Pfizer offers up to $250 million to settle Zantac cancer lawsuits, FT reports
Business|Health

No shortage of Wegovy weight-loss drug in Denmark, Novo Nordisk says

Novo Nordisk does not expect a shortage of its Wegovy weight-loss drug in Denmark despite an earlier warning by the Danish Medicines Agency of strained supply of two separate

No shortage of Wegovy weight-loss drug in Denmark, Novo Nordisk says
Business|Health

Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA

Eisai and partner Biogen said on Tuesday that the Japanese drugmaker has begun submitting data on a rolling basis to the US health regulator for a marketing application of a subcutaneous

Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
Health

Red Cross sets up Rafah emergency field hospital

The International Red Cross and partners are opening a field hospital in southern Gaza on Tuesday to try to meet what it described as "overwhelming" demand for health services since

Red Cross sets up Rafah emergency field hospital
Business|Economy|Health

Walgreens contacts potential buyers for Boots UK chain, Bloomberg News reports

Walgreens Boots Alliance is in the process of contacting potential buyers to sell its UK-based Boots drugstore chain in a second attempt at separating the unit, Bloomberg News reported on

Walgreens contacts potential buyers for Boots UK chain, Bloomberg News reports
Business|Health

J&J to exit spinoff Kenvue with latest stake sale

Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer

J&J to exit spinoff Kenvue with latest stake sale

Follow